PHILIP TALARICO: Open Payments
NPI 1356703193 · MEADVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,056 in 136 payments from 15 companies in 2025. Trend: 2023 $1,646 · 2024 $1,767 · 2025 $2,056
Food & beverage: $2,056
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 30 | $345 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $306 |
| Teva Pharmaceuticals USA, Inc. | 28 | $251 |
| Alkermes, Inc. | 13 | $213 |
| Janssen Pharmaceuticals, Inc | 7 | $140 |
| ABBVIE INC. | 12 | $140 |
| Otsuka America Pharmaceutical, Inc. | 5 | $113 |
| Lundbeck LLC | 5 | $99 |
| Vanda Pharmaceuticals Inc. | 3 | $87 |
| Neurocrine BioSciences, Inc. | 4 | $81 |
Products named: Auvelity, CAPLYTA, REXULTI, ARISTADA, AUSTEDO XR, INVEGA SUSTENNA, VRAYLAR, UZEDY.
Industry payments across PA — which companies pay providers there.
